GEHC on Nasdaq

GE HealthCare

Logo: GE HealthCare/Interbrand (design firm), Public domain, via Wikimedia Commons6

American multinational medical technology company

GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.3 Its shares trade on Nasdaq under the symbol GEHC.1 Wikipedia text CC BY-SA 4.0

$69.50 down 0.84 (1.20%)Price as of Oct 16, 2026 at 19:58 UTC

Last updated Oct 21, 2026.

Overview

2004Founded1

Compare with Hologic, Butterfly Network, Inc. or Nano-X Imaging, or pick any stock.

  • TickerGEHC on Nasdaq1
  • Industryelectronics, health care, industrial manufacturing, medical technology industry1
  • HeadquartersChicago1
  • Websitewww.gehealthcare.com
  • Legal formprivate company limited by shares1
  • Incorporated inDE7
  • Business address500 West Monroe Street, Chicago, Il 606617
  • Filer categoryLarge accelerated filer7
  • LEIVRA3J77FZVM3XWZYY0914
  • StatusActive4
  • LEI statusIssued and current4
  • Registered addressPOLLARDS WOOD, HP8 4SP Nightingales Lane, United Kingdom4
  • Registered withCompanies House, 010026104
CAT scanner
Photo: liz west from Boxborough, MA, CC BY 2.0, via Wikimedia Commons10

GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

40.0%Gross margin11
13.4%Operating margin11
10.1%Net margin11
4.8%Revenue growth, 202511
20.1%Return on equity11
0.91×Debt to equity11

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Product brought in 66% of the revenue GE HealthCare broke down this way in fiscal 2025.

  1. Product$13.7B1166%up 4% from 2024
  2. Service$7.0B1134%up 6% from 2024
Products and services by year
Products and services202320242025
Product$13.1B$13.1B$13.7B
Service$6.4B$6.6B$7.0B

Business segments

Imaging brought in 45% of the revenue GE HealthCare broke down this way in fiscal 2025.

  1. Imaging$9.2B1145%up 4% from 2024
  2. AVS$5.4B1126%up 4% from 2024
  3. PCS$3.1B1115%down 1% from 2024
  4. PDx$2.9B1114%up 16% from 2024
Business segments by year
Business segments202320242025
Imaging$8.9B$8.9B$9.2B
AVS$5.1B$5.1B$5.4B
PCS$3.1B$3.1B$3.1B
PDx$2.3B$2.5B$2.9B

Regions

Other Countries brought in 46% of the revenue GE HealthCare broke down this way in fiscal 2025.

  1. Other Countries$9.4B1146%up 6% from 2024
  2. United States$9.2B1144%up 6% from 2024
  3. China$2.0B1110%down 5% from 2024
Regions by year
Regions202320242025
Other Countries$8.8B$8.9B$9.4B
United States$8.2B$8.6B$9.2B
China$2.6B$2.1B$2.0B

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Research and development6¢$1.3B
  • Selling, general and admin20¢$4.2B
  • Other costs60¢$12.4B
  • Income tax3¢$614.0M
  • Profit10¢$2.1B

Out of $20.6B in revenue.11

Financial statements

Revenue121311$20.6B in 2025+17% since 2021
0$10.0B$20.0B$30.0B2021: $17.6B$17.6B20212022: $18.3B$18.3B2022+4%2023: $19.6B$19.6B2023+7%2024: $19.7B$19.7B2024+1%2025: $20.6B$20.6B2025+5%
Gross profit121311$8.2B in 2025+15% since 2021
0$2.5B$5.0B$7.5B$10.0B2021: $7.2B$7.2B20212022: $7.2B$7.2B2022+0%2023: $7.9B$7.9B2023+10%2024: $8.2B$8.2B2024+4%2025: $8.2B$8.2B2025+1%
Operating income121311$2.8B in 2025−1% since 2021
0$1.0B$2.0B$3.0B2021: $2.8B$2.8B20212022: $2.5B$2.5B2022−10%2023: $2.4B$2.4B2023−3%2024: $2.6B$2.6B2024+8%2025: $2.8B$2.8B2025+5%
Net income121311$2.1B in 2025−7% since 2021
0$1.0B$2.0B$3.0B2021: $2.2B$2.2B20212022: $1.9B$1.9B2022−15%2023: $1.6B$1.6B2023−18%2024: $2.0B$2.0B2024+27%2025: $2.1B$2.1B2025+5%

Every line of the income statement as filed: the last 3 fiscal years, latest first.11

Period ending2025-12-312024-12-312023-12-31
Total revenues$20.6B$19.7B$19.6B
Gross profit$8.2B$8.2B$7.9B
Selling, general, and administrative$4.2B$4.3B$4.3B
Research and development$1.3B$1.3B$1.2B
Total operating expenses$5.5B$5.6B$5.5B
Operating income$2.8B$2.6B$2.4B
Interest and other financial charges net$440.0M$504.0M$542.0M
Non-operating benefit (income) costs-$288.0M-$406.0M-$382.0M
Other (income) expense net-$157.0M-$55.0M-$86.0M
Income from continuing operations before income taxes$2.8B$2.6B$2.4B
Benefit (provision) for income taxes-$614.0M-$531.0M-$743.0M
Net income from continuing operations$2.2B$2.0B$1.6B
Income (loss) from discontinued operations, net of taxes$0$0-$4.0M
Net income$2.2B$2.0B$1.6B
Net (income) loss attributable to noncontrolling interests-$70.0M-$57.0M-$46.0M
Net income attributable to GE HealthCare$2.1B$2.0B$1.6B
Deemed preferred stock dividend of redeemable noncontrolling interest$0$0-$183.0M
Net income attributable to GE HealthCare common stockholders$2.1B$2.0B$1.4B
Basic (in dollars per share)$5$4$3
Diluted (in dollars per share)$5$4$3
Basic (in dollars per share)$4.56$4.37$3.05
Diluted (in dollars per share)$4.55$4.34$3.03
Basic (in shares)456.0M shares456.0M shares455.0M shares
Diluted (in shares)458.0M shares459.0M shares458.0M shares

Compare GE HealthCare with another company

Corporate structure

GE HealthCare is part of a group headed by GE Aerospace. 319 entities, 65 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of GE HealthCare

  • &. Cox Dodge Filed SCHEDULE 13G/A on GE HealthCare, latest Aug 7, 2026 (5 filings since Aug 13, 2025)
  • Capital Research Global Investors Filed SCHEDULE 13G/A on GE HealthCare, latest May 14, 2026 (7 filings since May 10, 2023)
  • VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on GE HealthCare, latest Apr 29, 2026
  • VANGUARD GROUP INC Filed SCHEDULE 13G/A on GE HealthCare, latest Mar 26, 2026 (4 filings since Feb 13, 2024)
  • BlackRock Filed SC 13G/A on GE HealthCare, latest Nov 8, 2024 (3 filings since Jan 29, 2024)
  • GENERAL ELECTRIC CO Filed SC 13G/A on GE HealthCare, latest Oct 22, 2024 (4 filings since Feb 10, 2023)
  • GE Aerospace Evendale, Ohio, United States
    • GE HealthCare Nightingales Lane, United Kingdom
      • Amersham plc Subsidiary · Chinnor, United Kingdom
      • GE Healthcare (India) Subsidiary
      • "GE HEALTHCARE TKT" LLC Subsidiary · Uzbekistan
      • 3238273 Nova Scotia Company Subsidiary · Canada
      • Beijing GE Hualun Medical Equipment Company Limited Subsidiary · China
      • BK Medical ApS Subsidiary · Denmark
      • BK Medical Australia Pty Ltd. Subsidiary · Australia
      • BK Medical Holding Company, Inc. Subsidiary · Delaware, United States
      • BK Medical Technology Shanghai Co., Ltd. Subsidiary · China
      • BKM Holding Company, Inc. Subsidiary · Delaware, United States
      • Caption Care PC, NJ Subsidiary · New Jersey, United States
      • Caption Health, Inc. Subsidiary · Delaware, United States
      • Critikon de Mexico, S. de R.L. de C.V. Subsidiary · Mexico
      • Datex-Ohmeda, Inc. Subsidiary · Delaware, United States
      • GE BE Private Ltd Subsidiary · India
      • GE Financial Markets Funding I Subsidiary · United Kingdom
      • GE Financial Markets Unlimited Company Subsidiary · Ireland
      • GE Hangwei Medical Systems Co., Ltd. Subsidiary · China
      • GE Healthcare (Austria) Subsidiary · Austria
      • GE HealthCare (Barbados) SRL Subsidiary · Barbados
      • GE Healthcare (Chengdu) Company Limited Subsidiary · China
      • GE Healthcare (China) Co., Ltd. Subsidiary · China
      • GE Healthcare (Netherlands) Subsidiary
      • GE Healthcare (Shanghai) Co Ltd Subsidiary · China
      • GE Healthcare (Tianjin) Co., Ltd. Subsidiary · China
      • and 172 more
    • GE Vernova (Switzerland) Baden, Switzerland
    • Engine Alliance Subsidiary · 50% · East Hartford
    • CFM International Subsidiary · Grand Prairie
    • GE Aviation Systems Subsidiary · Grand Rapids, Michigan, United States
    • GE Honda Aero Engines Subsidiary · Cincinnati
    • Walter Aircraft Engines Subsidiary · Prague
    • "LM WIND POWER BLADES (POLAND)" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Subsidiary · Goleniow, Poland
    • ALSTOM RENEWABLE VIETNAM LIMITED Subsidiary · Ha Noi, Vietnam
    • BHA GROUP INTERNATIONAL PRIVATE LIMITED Subsidiary · Pune, India
    • BIRCHWOOD POWER PARTNERS, L.P. Subsidiary · Stanford, Connecticut, United States
    • COGELEX Subsidiary · Issy-Les-Moulineaux, France
    • Daintree Networks Pty Ltd Subsidiary · Melbourne, Australia
    • GE AVIATION SYSTEMS GROUP LIMITED Subsidiary · Cheltenham, United Kingdom
    • GE AVIATION UK Subsidiary · Cheltenham, United Kingdom
    • GE BRAZIL HOLDING LIMITED Subsidiary · Breda, Netherlands
      • GE INDUSTRIAL CONSOLIDATION LIMITED Subsidiary · Altrincham, United Kingdom
    • GE CAPITAL INTERNATIONAL FUNDING COMPANY UNLIMITED COMPANY Subsidiary · Shannon, Ireland
    • GE CAPITAL INTERNATIONAL LIMITED Subsidiary · London, United Kingdom
    • GE ENERGY (USA), LLC Subsidiary · Wilmington, Delaware, United States
    • GE ENERGY INTERNATIONAL COÖPERATIEF U.A. Subsidiary · Breda, Netherlands
      • GE ALBANY GLOBAL HOLDINGS B.V. Subsidiary · Breda, Netherlands
        • ALSTOM VIETNAM COMPANY LIMITED Subsidiary · Ha Noi, Vietnam
        • GE EOLIENNES SN Subsidiary · Montoir-De-Bretagne, France
        • GE GRID ALLIANCE B.V. Subsidiary · Breda, Netherlands
          • 4 more
        • GE POWER SERVICES HELLAS S.A. Subsidiary · Marousi, Greece
    • GE ENERGY MANUFACTURING TECHNOLOGY CENTER FACTORY (مصنع مركز جنرال الكتريك لتكنولوجيا صناعة الطاقة) Subsidiary · Dammam, Saudi Arabia
    • GE Energy Parts, Inc. Subsidiary · Wilmington, Delaware, United States
    • GE ENERGY POWER CONVERSION GROUP Subsidiary · Issy-Les-Moulineaux, France
      • GE ENERGY POWER CONVERSION FRANCE Subsidiary · Massy, France
    • GE ENERGY POWER CONVERSION UK LIMITED Subsidiary · Rugby, United Kingdom
    • GE ENERGY POWER CONVERSION USA INC. Subsidiary · Wilmington, Delaware, United States
    • and 64 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What GE HealthCare reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$5.7B11 Dec 31, 2025$5.3B11 Dec 31, 2024+8.8%
Accumulated depreciation$3.0B11 Dec 31, 2025$3.1B11 Dec 31, 2024−1.0%
Operating-lease assets (leased space)$410.0M11 Dec 31, 2025$364.0M11 Dec 31, 2024+12.6%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$4.5B11 Dec 31, 2025$2.9B11 Dec 31, 2024+56.3%
Stakes in other companies (equity method)$28.0M11 Dec 31, 2025$163.0M11 Dec 31, 2024−82.8%
Long-term investments$351.0M11 Dec 31, 2025$373.0M11 Dec 31, 2024−5.9%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$13.5B11 Dec 31, 2025$13.1B11 Dec 31, 2024+2.7%
Intangible assets, net (excluding goodwill)$1.1B11 Dec 31, 2025$1.1B11 Dec 31, 2024+4.8%
Indefinite-lived intangibles (excluding goodwill)$75.0M11 Dec 31, 2025$74.0M11 Dec 31, 2024+1.4%
Finite-lived intangibles, gross$4.7B11 Dec 31, 2025$4.5B11 Dec 31, 2024+5.5%
Accumulated amortization$3.7B11 Dec 31, 2025$3.5B11 Dec 31, 2024+5.6%
Finite-lived intangibles, net$1.1B11 Dec 31, 2025$1.0B11 Dec 31, 2024+5.1%

Inventory

ItemLatestA year beforeChange
Inventory, total$2.2B11 Dec 31, 2025$1.9B11 Dec 31, 2024+15.2%
Raw materials$1.0B11 Dec 31, 2025$921.0M11 Dec 31, 2024+8.8%
Work in process$95.0M11 Dec 31, 2025$92.0M11 Dec 31, 2024+3.3%
Finished goods$1.1B11 Dec 31, 2025$926.0M11 Dec 31, 2024+22.8%

Properties, in its own words

GE HealthCare is a global organization headquartered in Chicago, Illinois with other major centers in or near the following cities: Milwaukee, Paris, Bangalore, and Shanghai. We own or lease over 300 facilities around the world excluding third-party logistics sites. We have 44 manufacturing facilities, of which 32 are owned. We have 14 manufacturing facilities located in the United States and 30 located outside of the United States, including in China, Japan, Mexico, Norway, India, Israel, Germany, Brazil, Austria, Denmark, France, Ireland, the Netherlands, Sweden, Finland, and South Korea. Many of these facilities serve more than one business line and may be used for multiple purposes, such as administration, sales, research, manufacturing, warehousing, service, and distribution. We consider our facilities suitable and adequate for the purposes for which they are used and do not anticipate difficulty in renewing existing leases as they expire or in finding alternative facilities.

Item 2 of the 10-K filed Feb 4, 2026.17

The story

Founding and early growth

GE HealthCare traces its roots to the Victor Electric Company, founded in 1893 in a basement by Charles F. Samms and Julius B. Wantz, previously employees of the assembly lines at the Knapp Electrical Works and Midland Electric Co. and then in their early 20s. They initially focused on supplies for the dental industry. At the time, they were a six-person operation.

By 1896, one year after Wilhelm Röntgen's discovery, Victor Electric entered the business for X-ray machines. The business expanded rapidly and so, in 1896, the company moved into new premises three times the original size. By 1896, the company also made electrostatic generators for exciting X-ray tubes and electrotherapeutic devices.

By 1903, Victor Electric had outgrown its facilities at 418 Dearborn St. in Chicago and acquired two floors of a building at 55 Market Street, Chicago. This was again only a temporary stop; by 1910 it was too small and the firm moved again in 1911 to a building at the corner of Jackson Blvd. and Damen Avenue. This was the first permanent home of Victor Electric Co. They stayed there 35 years and during this time, gradually acquired all the space in the building and several around it.

In 1916, the company merged with three companies: Scheidel Western, Snook-Roentgen, MacAlaster & Wiggin. Victor's two founders had key roles in the new firm; Charles F. Samms was company president and Julius B. Wantz was Vice-President of manufacturing and engineering.

Acquisition by General Electric

In 1920, GE HealthCare entered the imaging technology business with the acquisition of Victor Electric Company, founded in 1893. By 1930 it was renamed to GE X-Ray; Before the introduction of the CT scanner in the 1970s and the MRI scanner in the 1980s, it declined to around 2% of GE's sales among the 120 departments in the conglomerate.

In the 1990s the department began to diversify into various medtech businesses and executed 94 acquisitions between 1995 and 2017. It also continued to invest in research and development, with over 3800 patents between 2000 and 2009.

Moving from X-Rays to Medical as GE Medical System

Use of X-rays in industry for non-destructive testing of war materials increased during World War II. X-rays were broadly used as a medical tool for military services.

As the war ended, GE X-Ray Corporation continued to grow. Greater production capacity and greater expertise was needed in the core business of building X-ray tubes. Since the tubes were made from hand-blown glass, the decision was made to move the company 90 miles north to Milwaukee, Wisconsin, in order to tap into the enormous amount of glass-blowing talent in Milwaukee's beer-brewing industry.

Read the full text

In 1947, the company moved from Jackson Blvd. in Chicago to a 43-acre (170,000 m2) site in the city of West Milwaukee, which had been used for building turbochargers during the war. The street was renamed Electric Avenue.

In 1951, the corporate structure was dissolved and the name changed to General Electric X-Ray Department. This new name lasted less than 10 years as the department divested itself of its industrial X-ray business, widened its medical business, and took on the name of GE Medical Systems Department. One of the reasons for the name of Medical Systems was due to the increase in the electro-medical business, which began in 1961 with the introduction of patient monitoring equipment. By 1967 modular equipment was developed which was soon popular in cardiac and intensive care units.

Early in 1960, pacemakers were developed in Corporate Research & Development in Schenectady, New York, and in 1969 the Standby Pacemaker was developed. In 1968, the Biomedical Business Section opened its first factory in Edgerton Avenue. Late in 1970 a surgical package was introduced and in 1971, equipment to monitor blood gasses during surgery was introduced.

Later in 1971, Biomedical opened a 9,000 square meter admin and engineering building opposite its factory and in 1972, the section was renamed The cardio-Surgical Product Section. With the growth of its medical business, the General Electric Company upgraded the department to The Medical Systems Division in 1971. Also in 1971, a major expansion programme was started and the Waukesha factory was planned. Work started in July 1972, and was completed in 1973.

In the 1970s, CT scanners were introduced, followed by MRI machines in the 1980s, and GE became a major manufacturer of both. The department, named GE Medical Systems (GEMS), grew rapidly under the management of Jack Welch, establishing international partnerships and acquisitions. It expanded to sell globally, including various partnerships and acquisitions, growing to 50% sales outside the USA by 1988.

Growth in the 1980s as GE Medical Systems

In 1982, the company set up a joint venture with Yokogawa Electric. It changed its name to GE HealthCare Japan Corporation in 2009.

In 1983, GE Medical started investing heavily in Magnetic Resonance Imaging (MRI) technology, investing nearly US$1 billion in a new plant in Waukesha. It developed the MR Signa, which became very successful. Up to this time, the medical Systems Division had simply been divided into domestic and international, but in 1987 it reorganized into the three "poles" of America, Europe and Pacific.

In 1985 GE acquired Technicare from Johnson and Johnson. Originally named Ohio Nuclear (and in 1979, after another fusion, Ohio Nuclear Unirad), the name was changed to Technicare in 1982. Technicare (with headquarters in Cleveland, Ohio) had been producing a range of rotate-stationary CTs with an installed base in the thousands, as well as some X-ray diagnostic equipment and a nascent MRI product range.

In 1988, GE Medical Europe merged with CGR (Compagnie Générale de Radiologie), a medical equipment supplier based in France, to form General Electric CGR Medical Systems. The European headquarters were moved from Hammersmith (UK) to Buc, Yvelines, near Paris.

Expanding in the 1990s as GE Medical Systems

In 1920, Victor was acquired by General Electric and was renamed VICTOR X-RAY CORPORATION. At that time, it was the largest manufacturer of X-ray tubes.

The merger of the Victor subsidiary and General Electric closed on July 28, 1926 and the company became "General Electric X-Ray Corporation". The merger brought renewed vitality to the organization and Victor entered the foreign market with equipment sold and serviced in nearly 70 countries. In 1930, the Victor name was phased-out from all branding; however, advertisements did mention "formerly Victor X-Ray Corporation".

In 1974, work on CT was started and the first CT machine was installed in 1976. In June 1980, the company acquired the CT scanner business of EMI.

The MRI magnet plant in Florence, South Carolina, was opened a short time later, giving GE its own magnet production. It underwent a $40 million expansion in 2017.

GE HealthCare was incorporated in 1994.

In 1992, GE acquired the Picker Service organization in the U.K.

In 1994, it changed the name in Europe from GE-CGR back to General Electric Medical Systems.

In September 1995, the company acquired Resonex, an MRI maker based in Fremont, California.

In 1996, Jeff Immelt was named CEO of the company; he became CEO of GE in 2000.

In April 1998, the company acquired Diasonics Vingmed from Elbit Medical Imaging of Haifa, Israel, expanding its ultrasound imaging business.

In September 1998, the company acquired Marquette Medical Systems for $808 million.

In November 1998, the company acquired the Nuclear and MR businesses of Elscint, (then a division of Elron, based in Haifa, Israel), for $100 million.

2000–2005

In September 2000, the company acquired the remaining 50% of the ELGEMS joint-venture formed with Elscint in 1997.

In 2001, the company acquired San Francisco, California–based CT maker Imatron for $210 million. Imatron produced an Electron beam tomography (EBT) scanner that performs imaging applications used by physicians specializing in cardiology, pulmonology and gastroenterology. The Imatron business was later incorporated into GE HealthCare's Diagnostic Imaging business segment.

In March 2002, the company acquired MedicaLogic, creator of the former Logician, an ambulatory Electronic Medical Records system, for approximately $32 million.

In April 2002, GE HealthCare acquired Visualization Technology, a manufacturer of intra-operative medical devices and related products for use in minimally invasive image guided surgery, based in Boston.

In January 2003, the company acquired Millbrook Corporation, maker of Millbrook Practice Manager, a billing and scheduling system for doctors' offices.

GE HealthCare IT later merged the two products into one, although the stand-alone EMR product is still available and in development.

In 2003, GE HealthCare acquired Instrumentarium, including its Datex-Ohmeda division, a producer, manufacturer, and supplier of anesthesia machines and mechanical ventilators. To satisfy regulatory concerns in the United States and in Europe, GE HealthCare was forced to divest Instrumentarium's Ziehm Imaging mobile C-arm business, as well as its Spacelabs patient-monitoring unit.

In April 2004, the company acquired Amersham plc.

Also in 2004, GE HealthCare along with other healthcare companies built a research reactor for neutron and unit cell research at GE's European Research Center near Garching (outside of Munich), Germany. It is the only such reactor currently in operation.

2006–2014

In 2006, Sir William Castell resigned as CEO to become Chairman of the Wellcome Trust, a charity that fosters and promotes human and animal research—in the United Kingdom. Former GE Medical Systems CEO Joe Hogan then became CEO.

In January 2006, the company acquired IDX Systems Corporation for $1.2 billion. IDX was folded into GE HealthCare Integrated IT Solutions, which specializes in clinical information systems and healthcare revenue management.

January 2007, The U.S. Food and Drug Administration stopped GE OEC the Salt Lake-based design and manufacturing plant from selling its surgical imaging systems stating that the OEC systems could put patients at risk.[27]

In February 2008, GE HealthCare acquired Whatman plc, a global supplier of filtration products and technologies for £363 million.

In July 2008, Joseph Hogan announced his intent to leave his post as CEO of GE HealthCare to take the role of CEO at ABB. John Dineen, head of GE's Transportation division since 2005, was named CEO.

In March 2010, the company acquired MedPlexus. The company then offered its first electronic medical record product in a software-as-a-service platform.

In April 2010, the company announced it was investing €3 million in the Technology Research for Independent Living Centre. The Irish centre seeks to enhance independence for elderly people through technological innovation.

2015–2020

In July 2015, GE HealthCare partnered with the 2015 CrossFit Games to provide athletes with mobile imaging equipment.

The following year in January 2016, the company announced the move of its global headquarters to Chicago.

In June 2017, Kieran Murphy was named CEO of the company, and former CEO John L. Flannery was named CEO of GE.

In April 2018, GE HealthCare sold several healthcare information technology assets to Veritas Capital for $1.05 billion.

In June 2018, GE first announced plans to spin off GE HealthCare. However, the plan was delayed after GE sold its biopharma business to Danaher Corporation for $21.4 billion.

2021–2025

In January 2021, the company acquired Prismatic Sensors AB, focused on Deep Silicon detector technology. A few months later in May 2021, the company acquired Zionexa, a company focused on biomarkers for the detection of breast cancer.

In July 2021, the company integrated technology from Spectronic Medical to create artificial intelligence-based software.

In November 2021, General Electric announced it would split into three publicly traded companies, with GE HealthCare being one of the three. The spin-off of GE HealthCare was completed on January 4, 2023. Prior to the spin-off, the company acquired BK Medical from Altaris Capital Partners for $1.45 billion.

Following its separation, GE HealthCare continued to expand. In February 2023, the company acquired Caption Health, an artificial intelligence medical technology manufacturer headquartered in San Mateo, California, for $150 million.

In July 2024, the company acquired the clinical artificial intelligence business from Intelligent Ultrasound for $51 million.

In March 2025, GE HealthCare introduced the Freelium sealed magnet platform for magnetic resonance imaging (MRI). The system uses less than 1% of the helium required by traditional imaging systems, and is intended to support more sustainable imaging and improve access to imaging in regions with limited helium supply.

In April 2025, GE HealthCare entered a partnership with FPT. A few months later they established a multi-year collaboration with Ascension, a non-profit health system. The two companies plan to work together to improve Ascension's patient access, safety, and care quality.

In November 2025, the company entered an agreement to acquire Intelerad Medical Systems for $2.3 billion.

From Wikipedia’s article on GE HealthCare, shared under CC BY-SA 4.0.8

Leadership

Who has led GE HealthCare, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (22)

Products and brands

Business overview

For 2024, the company reported nearly $20 billion in total revenue split between about $13 billion in products and about $6.6 billion in services, growing by 2% from the prior year.

As of 2025, the company reports its revenue broken down into four segments in accordance with the segment reporting accounting requirements (ASU 2023-07):

Imaging, which accounted for about $2.4 billion in 2024Q4

Advanced Visualization Solutions, with $1.4 billion in 2024Q4

Read the full text

Patient Care Solutions, with $827 million in 2024Q4

Pharmaceutical Diagnostics with $646 million 2024Q4

Major competitors include Fujifilm, Siemens Healthineers, and other companies in the medical imaging industry.

Imaging

The imaging business was the original core starting with x-rays in 1920, CT scanners in the 1970s, and MRI machines in the 1980s.

As of 2024, it includes the original imaging businesses along with continued innovations, such as the digital Omni Legend PET/CT scanner introduced in 2022.

GE uses a custom scientific Linux distribution HELiOS (Healthcare Enterprise Linux Operating System) on their machines. They partnered with SUSE in 2020.

Facilities

The company's headquarters are in Chicago on the sixteenth floor of the Heller International Building. In 2019, it consolidated hundreds of employees, particularly in technology, from Barrington, Illinois to its Chicago headquarters. In 2020, it relocated salespeople to the headquarters from Wisconsin or regional sales offices countrywide.

The company has a major presence in Waukesha, Wisconsin, where as of 2023 over half of its 5200 Wisconsin employees were located. The company collaborates with researchers at University of Wisconsin-Madison which is less than 80 miles away.

Manufacturing factories

As of 2024, around two-thirds of CT scanners are produced in China, particularly in the Beijing Economic-Technological Development Area where GE launched its first joint venture, GE Hangwei Medical Systems, Co., Ltd., in China in 1991. GE also has a manufacturing facility in India, which launched in 2022.

As of 2023, the company has a manufacturing plant in 4855 W. Electric Ave., West Milwaukee which produces imaging tubes and detectors. It announced plans to expand the plant in 2020 to produce more components for PET and CT scanners. The company began its presence in the region in 1947 during a post-World War II shift by GE X-Ray.

The company has a plant in North Aurora, Illinois; in 2025, workers there voted to join the International Association of Machinists and Aerospace Workers (IAM), which also represents workers in Warrensville Heights, Ohio and Wisconsin.

In 2009, a new 230k square foot plant in Troy, New York was completed for manufacturing digital mammography x-ray machines, incorporating digital flat panel X-ray technology using research conducted in Niskayuna, New York.

From Wikipedia’s article on GE HealthCare, shared under CC BY-SA 4.0.8

Subsidiaries and ownership

Owners

Subsidiaries

Parent company (GLEIF)

Subsidiaries (Exhibit 21)

  • "GE HEALTHCARE TKT" LLC Uzbekistan9
  • 3238273 Nova Scotia Company Canada9
  • BK Medical ApS Denmark9
  • BK Medical Australia Pty Ltd. Australia9
  • BK Medical Holding Company, Inc. Delaware9
  • BK Medical Technology Shanghai Co., Ltd. China9
  • BKM Holding Company, Inc. Delaware9
  • Beijing GE Hualun Medical Equipment Company Limited China9
  • Caption Care PC, NJ New Jersey9
  • Caption Health, Inc. Delaware9
  • Critikon de Mexico, S. de R.L. de C.V. Mexico9
  • Datex-Ohmeda, Inc. Delaware9
  • GE BE Private Ltd India9
  • GE Financial Markets Funding I United Kingdom9
  • GE Financial Markets Unlimited Company Ireland9
  • GE HEALTHCARE PHARMACEUTICAL, COMMERCIAL AND INDUSTRIAL SOCIETE ANONYME Greece9
  • GE HFS, LLC Delaware9
  • GE Hangwei Medical Systems Co., Ltd. China9
  • GE HealthCare (Barbados) SRL Barbados9
  • GE HealthCare Canada Financial Services Company Canada9
  • GE HealthCare Canada Holdings Canada9
  • GE HealthCare Canada Investments Holdings Canada9
  • GE HealthCare Canada Property Inc. Canada9
  • GE HealthCare Caribbean Export LLC Delaware9
All 219 listed subsidiaries
  • GE HealthCare Finance Leasing (China) Co., Ltd. China9
  • GE HealthCare Financial Markets US Holdings Inc. Delaware9
  • GE HealthCare Financial Services Ltd United Kingdom9
  • GE HealthCare Financial Services Pte. Ltd. Singapore9
  • GE HealthCare Holding France SAS France9
  • GE HealthCare Imaging Holding Inc. Delaware9
  • GE HealthCare Industrial France France9
  • GE HealthCare International Benelux B.V. Netherlands9
  • GE HealthCare International Japan Investments B.V. Netherlands9
  • GE HealthCare Investment (China) Co., Ltd. China9
  • GE HealthCare Japan Investments Cooperatief U.A. Netherlands9
  • GE HealthCare Kazakhstan LLP Kazakhstan9
  • GE HealthCare Korea, Inc. Korea, Republic Of (South)9
  • GE HealthCare Medical Technology LLC Delaware9
  • GE HealthCare Nova Scotia #1 Company Canada9
  • GE HealthCare Nova Scotia #2 Company Canada9
  • GE HealthCare PC Nova Scotia Company Canada9
  • GE HealthCare Philippines, Inc. Philippines9
  • GE HealthCare Regional Head Quarters Single Person Company Saudi Arabia9
  • GE HealthCare Research and Development (Shanghai) Co., Ltd. China9
  • GE HealthCare Slovensko, s.r.o. Slovakia9
  • GE HealthCare Technologies Canada Canada9
  • GE HealthCare Technologies Canada Company Canada9
  • GE HealthCare Technologies France SAS France9
  • GE HealthCare Technologies Inc. Delaware9
  • GE HealthCare Technologies Pacific Private Limited Singapore9
  • GE HealthCare Transnational Holdings, LLC Delaware9
  • GE HealthCare UK Holdings United Kingdom9
  • GE HealthCare VFS Canada Limited Partnership Canada9
  • GE HealthCare Ventures Investment (Hangzhou) Co., Ltd. China9
  • GE HealthCare Ventures Investment Management (Hangzhou) Co., Ltd. China9
  • GE HealthCare d.o.o Beograd (Novi Beograd) Serbia9
  • GE HealthCare Česká republika,s.r.o Czech Republic9
  • GE Healthcare (AB) United Kingdom9
  • GE Healthcare (Chengdu) Company Limited China9
  • GE Healthcare (China) Co., Ltd. China9
  • GE Healthcare (Pty) Ltd South Africa9
  • GE Healthcare (Shanghai) Co Ltd China9
  • GE Healthcare (Tianjin) Co., Ltd. China9
  • GE Healthcare A/S Denmark9
  • GE Healthcare AB Sweden9
  • GE Healthcare AG Switzerland9
  • GE Healthcare AS Norway9
  • GE Healthcare Algerie SARL Algeria9
  • GE Healthcare Argentina S.A. Argentina9
  • GE Healthcare Australia Holdings Pty Ltd Australia9
  • GE Healthcare Australia Pty Limited Australia9
  • GE Healthcare Austria GmbH & Co OG Austria9
  • GE Healthcare B.V. Netherlands9
  • GE Healthcare BV Belgium9
  • GE Healthcare Bangladesh Limited Bangladesh9
  • GE Healthcare Bio-Sciences, S.A.U. Spain9
  • GE Healthcare Buchler GmbH Germany9
  • GE Healthcare Buchler GmbH & Co. KG Germany9
  • GE Healthcare Bulgaria EOOD Bulgaria9
  • GE Healthcare Canada Inc. Canada9
  • GE Healthcare Clinical Systems Norway AS Norway9
  • GE Healthcare Colombia SAS Colombia9
  • GE Healthcare Danmark A/S Denmark9
  • GE Healthcare Equipment Finance France9
  • GE Healthcare Estonia OU Estonia9
  • GE Healthcare Europe Holding B.V. Netherlands9
  • GE Healthcare FZE United Arab Emirates9
  • GE Healthcare Financial Services GmbH Germany9
  • GE Healthcare Finland Oy Finland9
  • GE Healthcare Funding Ireland Unlimited Company Ireland9
  • GE Healthcare Global Holdings, Inc. Delaware9
  • GE Healthcare Global Parts Company, Inc. Delaware9
  • GE Healthcare Global Private Limited India9
  • GE Healthcare GmbH Germany9
  • GE Healthcare Handels GmbH Austria9
  • GE Healthcare Holding AS Norway9
  • GE Healthcare Holding Germany GmbH Germany9
  • GE Healthcare Holding Norge AS Norway9
  • GE Healthcare Holding SAS France9
  • GE Healthcare Holdings Austria GmbH Austria9
  • GE Healthcare Holdings Inc. Delaware9
  • GE Healthcare IITS USA Corp. Vermont9
  • GE Healthcare IVD (Netherlands) B.V. Netherlands9
  • GE Healthcare Inc. Delaware9
  • GE Healthcare Information Technologies GmbH & Co. KG Germany9
  • GE Healthcare International LLC Delaware9
  • GE Healthcare Ireland Limited Ireland9
  • GE Healthcare Italia Holding S.r.l. Italy9
  • GE Healthcare Japan Corporation Japan9
  • GE Healthcare Kenya Limited Kenya9
  • GE Healthcare Limited United Kingdom9
  • GE Healthcare Magyarorszag Kft. Hungary9
  • GE Healthcare Manufacturing LLC Delaware9
  • GE Healthcare Norge AS Norway9
  • GE Healthcare Norway Holding AS Norway9
  • GE Healthcare Oy Finland9
  • GE Healthcare Pakistan (Private) Limited Pakistan9
  • GE Healthcare Pension Trustee Limited United Kingdom9
  • GE Healthcare Pharma Limited Japan9
  • GE Healthcare Pharma Limited Liability Company Russia9
  • GE Healthcare Pharmaceutical Diagnostics Holding Ltd United Kingdom9
  • GE Healthcare Pte Ltd Singapore9
  • GE Healthcare SAS France9
  • GE Healthcare Sdn Bhd Malaysia9
  • GE Healthcare Services Italy S.r.l. Italy9
  • GE Healthcare Srl Italy9
  • GE Healthcare Structured Projects (UK) Limited United Kingdom9
  • GE Healthcare Sverige AB Sweden9
  • GE Healthcare Technologies Holding Limited United Kingdom9
  • GE Healthcare Trade and Development LLC Delaware9
  • GE Healthcare Treasury Services Unlimited Company Ireland9
  • GE Healthcare Tunisia SARL Tunisia9
  • GE Healthcare UK Limited United Kingdom9
  • GE Healthcare USA Holding LLC Delaware9
  • GE Healthcare Ukraine LLC Ukraine9
  • GE Healthcare Unidad Central de Radiofarmacia de Galicia, S.L. Spain9
  • GE Healthcare Vietnam Company Ltd Vietnam9
  • GE Healthcare del Peru S.A.C. Peru9
  • GE Healthcare do Brasil Comercio e Servicos para Equipamentos Medico-Hospitalares Ltda. Brazil9
  • GE Lighting Philippines, Inc. Philippines9
  • GE Medical Holding AB Sweden9
  • GE Medical Systems (China) Co., Ltd. China9
  • GE Medical Systems (Schweiz) AG Switzerland9
  • GE Medical Systems (Thailand) Ltd. Thailand9
  • GE Medical Systems Egypt LLC Egypt9
  • GE Medical Systems Hong Kong Limited Hong Kong9
  • GE Medical Systems Information Technologies GmbH Germany9
  • GE Medical Systems Information Technologies, Inc. Wisconsin9
  • GE Medical Systems Ireland Limited Ireland9
  • GE Medical Systems Israel Ltd Israel9
  • GE Medical Systems Italia SpA Italy9
  • GE Medical Systems Limited United Kingdom9
  • GE Medical Systems Monterrey-Mexico, S.A. de C.V. Mexico9
  • GE Medical Systems Polska Sp. z o.o. Poland9
  • GE Medical Systems Societe en Commandite Simple France9
  • GE Medical Systems South Africa (Pty) Ltd South Africa9
  • GE Medical Systems Sweden AB Sweden9
  • GE Medical Systems Taiwan Limited Taiwan9
  • GE Medical Systems Trade and Development (Shanghai) Co., Ltd. China9
  • GE Medical Systems Turkiye Limited Sirketi Turkey9
  • GE Medical Systems, L.L.C. Delaware9
  • GE Medical Systems, Ultrasound & Primary Care Diagnostics, LLC Delaware9
  • GE Medical Technologies Nigeria Ltd Nigeria9
  • GE Medical for Trading Ltd Egypt9
  • GE Middle East Healthcare Services Jordan9
  • GE Parallel Design Inc. Delaware9
  • GE Precision Healthcare LLC Delaware9
  • GE Sistemas Medicos de Mexico, SA de CV Mexico9
  • GE Ultrasound Korea Limited Korea, Republic Of (South)9
  • GE Vingmed Ultrasound A/S Norway9
  • GEFM Edinburgh I Limited United Kingdom9
  • GEMS PET Systems AB Sweden9
  • General Electric Healthcare Arabia Company Limited Saudi Arabia9
  • General Electric Healthcare Espana, SA Spain9
  • General Electric Healthcare Lanka (Private) Limited Sri Lanka9
  • General Electric Healthcare Portugal, Sociedade Unipessoal, Lda Portugal9
  • General Electric Medical Systems Middle East Ltd Egypt9
  • General Electric Medical Systems Romania S.r.l. Romania9
  • Gold Seal Renewable Resources (Tianjin) Co., Ltd. China9
  • IDX Systems Corporation Vermont9
  • Icometrix N.V. Belgium9
  • Imactis SAS France9
  • Instrumentarium Holdings, Inc. Delaware9
  • Intelligent Ultrasound Ltd. United Kingdom9
  • Kiinteisto Oy Puustellintie 3 Finland9
  • Kiinteisto Oy Teollisuuskatu 29 Finland9
  • Limited Liability Company GE Healthcare Russia9
  • MIM Software Beijing Co., Ltd. China9
  • MIM Software Brussels BV Belgium9
  • MIM Software Inc. Ohio9
  • Medi-Physics, Inc. Delaware9
  • NMP Business Support Company, Limited Japan9
  • Nihon Medi-Physics Co., Ltd. Japan9
  • OEC Medical Systems, Inc. Delaware9
  • OY GE Healthcare Bio-Sciences AB Finland9
  • One GE Healthcare UK United Kingdom9
  • PRECISION HEALTHCARE TREASURY APAC PTE. LTD. Singapore9
  • PT GE Lighting Indonesia Indonesia9
  • PT GE Operations Indonesia Indonesia9
  • Parallel Design SAS France9
  • Prismatic Sensors AB Sweden9
  • Radiopharma Braunschweig Management GmbH Germany9
  • Radiopharma Braunschweig Manufacturing GmbH & Co. KG Germany9
  • Research Circle Technology, Inc. Delaware9
  • SATIS - Radioisotopos e Proteccoes contra Sobretensoes Electricas, Lda Portugal9
  • Saudi American General Electric Company Limited Saudi Arabia9
  • Schleifring Medical Systems, LLC Delaware9
  • Sound Technology, Inc. Pennsylvania9
  • Spectronic Medical AB Sweden9
  • The Radiochemical Centre GmbH Germany9
  • U-Systems, Inc. Delaware9
  • USA Instruments, Inc Ohio9
  • Ultrasonix Medical Corporation Canada9
  • VersaMed Corporation Delaware9
  • VersaMed Medical Systems Ltd. Israel9
  • Whatman Asia Pacific Private Ltd. Singapore9
  • Wipro GE Healthcare Private Limited India9
  • Wipro GE Medical Device Manufacturing Private Limited India9
  • icometrix Inc. Delaware9

From Wikidata.1 Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record. The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Acquisitions

  1. Apr 8, 2004Acquired Amersham plc1

Former names

  • GE Healthcare Holding LLCJul 29, 2022 to Dec 14, 20227

Timeline

  1. Sep 22, 20268-K Executive or director change; Regulation FD disclosure48
  2. Aug 18, 20268-K Executive or director change49
  3. Jul 29, 20268-K Results of operations50
  4. Jul 29, 20268-K Regulation FD disclosure51
  5. Jul 23, 20268-K Results of operations; Executive or director change52
  6. May 11, 20268-K Shareholder vote; Other events53
  7. Apr 29, 20268-K Results of operations54
  8. Mar 17, 20268-K Executive or director change; Regulation FD disclosure55
  9. Feb 27, 20268-K Entered a material agreement; Ended a material agreement; New debt or obligation56
  10. Feb 4, 20268-K Results of operations57
  11. Dec 15, 20258-K Entered a material agreement; New debt or obligation; Other events58
  12. Dec 2, 20258-K Other events59
  13. May 1, 2025New chief executive Jeannette Bankes becomes CEO18
  14. Jul 1, 2024New chief executive Philip Rackliffe becomes CEO19
  15. Jan 5, 2023New chief executive Thomas J. Westrick becomes CEO23
  16. Jan 5, 2023New chief executive Roland Rott becomes CEO22
  17. Jan 5, 2023New chief executive Kevin Michael O'Neill becomes CEO21
  18. Jan 5, 2023New chief executive Jan Makela becomes CEO20
  19. Dec 14, 2022New chief executive Peter Arduini becomes CEO24
  20. Feb 7, 2018Parent Directly consolidated by GE Aerospace4
  21. 2004Founded Founded1

Calendar

Coming up

  1. Oct 23, 2026Dividend Ex-dividend; $0.04 a share; paid 2026-11-13.60
  2. Oct 28, 2026 · Before the openReports results for the quarter ending Sep/2026 A year earlier it reported $1.07 a share, on Oct 29, 2025.61

When it reported results

  1. Jul 29, 2026Reported quarterly or annual results50
  2. Jul 23, 2026Reported quarterly or annual results52
  3. Apr 29, 2026Reported quarterly or annual results54
  4. Feb 4, 2026Reported quarterly or annual results57
  5. Oct 29, 2025Reported quarterly or annual results62
  6. Jul 30, 2025Reported quarterly or annual results63
  7. Apr 30, 2025Reported quarterly or annual results64
  8. Feb 13, 2025Reported quarterly or annual results65

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

442 filings to the SEC since October 2021: 4 annual reports, 11 quarterly reports, 55 major events, 254 insider forms, 24 large holders, 94 other. The latest 20:

  1. Sep 22, 20268-K EDGAR
  2. Sep 16, 20264 EDGAR
  3. Sep 16, 20263 EDGAR
  4. Sep 4, 20264 EDGAR
  5. Sep 4, 20264 EDGAR
  6. Sep 4, 20264 EDGAR
  7. Sep 4, 20264 EDGAR
  8. Sep 4, 20264 EDGAR
  9. Sep 4, 20264 EDGAR
  10. Sep 4, 20264 EDGAR
  11. Sep 4, 20264 EDGAR
  12. Sep 3, 20264 EDGAR
  13. Sep 3, 20264 EDGAR
  14. Sep 3, 20264 EDGAR
  15. Sep 3, 20264 EDGAR
  16. Sep 3, 20264 EDGAR
  17. Sep 3, 20264 EDGAR
  18. Aug 18, 20268-K EDGAR
  19. Aug 18, 20264 EDGAR
  20. Aug 7, 2026SCHEDULE 13G/A EDGAR

The 442 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

21 open-market trades by officers, directors and large owners since October 2021: 10 buys and 11 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
May 22, 2026Lobo KevinDirectorBuy10,000$64.18$641.8KForm 4
May 12, 2026Hochman Rodney FDirectorBuy1,618$62.03$100.4KForm 4
May 8, 2026Yang Watkin Phoebe L.DirectorBuy1,000$63.01$63.0KForm 4
May 6, 2026Stromberg William JDirectorBuy1,000$61.69$61.7KForm 4
May 6, 2026CULP H LAWRENCE JRDirectorBuy80,805$61.88$5.0MForm 4
May 1, 2026SACCARO JAMESChief Financial OfficerBuy3,310$60.60$200.6KForm 4
Apr 30, 2026Jimenez Frank RGC & Corporate SecretaryBuy1,750$60.45$105.8KForm 4
Apr 30, 2026Arduini Peter JPresident and CEOBuy4,169$59.93$249.8KForm 4
Feb 18, 2025Newcomb George A.Chief Accounting OfficerSale2,000$92.54$185.1KForm 4
Nov 6, 2024Rott RolandCEO, ImagingSale3,577$86.48$309.3KForm 4
Nov 5, 2024Rackliffe PhilipCEO, AISSale900$87.63$78.9KForm 4
Aug 14, 2024Stacherski Kenneth R.Chief Enterprise Oper. OfficerSale19,008$83.22$1.6MForm 4
Aug 7, 2024Westrick Thomas J.CEO, Patient Care SolutionsSale2,750$80.78$222.1KForm 4
May 28, 2024Kass-Hout TahaChief Technology OfficerSale3,300$78.70$259.7KForm 4
May 15, 2024Makela JanCEO, ImagingSale66,955$81.54$5.5MForm 4
May 13, 2024Makela JanCEO, ImagingSale20,227$81.57$1.6MForm 4
May 1, 2024Jimenez Frank RGC & Corporate SecretaryBuy1,315$76.52$100.6KForm 4
Jul 31, 2023O'Neill Kevin MichaelCEO, PDxSale15,609$77.32$1.2MForm 4
Jun 8, 2023Rott RolandCEO, ImagingSale2,473$77.37$191.3KForm 4
Mar 14, 2023Makela JanCEO, ImagingSale70,629$77.69$5.5MForm 4

All 21 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025President and CEO$1.3M$18.6M72
2025Chief Science and Technology Officer$897.1K$6.0M72
2025VP and CFO$890.4K$5.9M72
2025General Counsel and Corporate Secretary$890.4K$5.5M72
2024President and CEO$1.3M$19.5M72
2024Chief Science and Technology Officer$897.1K$5.7M72
2024VP and CFO$872.2K$5.7M72
2024General Counsel and Corporate Secretary$872.2K$5.4M72
2023President and CEO$1.2M$24.5M72
2023Chief Science and Technology Officer$876.4K$13.9M72
2023VP and CFO$493.1K$11.0M72
2023General Counsel and Corporate Secretary$871.6K$7.5M72

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Dodge & Cox37,864,164$2.4B1.3%+6,552,100
BlackRock, Inc.37,467,843$2.4B0.0%+1,483,516
Vanguard Capital Management LLC29,724,359$1.9B0.0%+860,171
State Street Corp20,861,566$1.3B0.0%+323,090
Vanguard Portfolio Management LLC20,275,526$1.3B0.1%+1,092,369
Invesco Ltd.18,296,350$1.2B0.1%+992,911
Harris Associates L P15,329,664$981.3M1.3%−265,324
Barrow Hanley Mewhinney & Strauss LLC13,455,814$861.3M2.6%+1,571,226
Geode Capital Management, LLC12,871,800$820.8M0.0%+472,165
Hotchkis & Wiley Capital Management LLC12,250,502$784.2M2.3%+2,282,629
Jpmorgan Chase & Co10,329,164$671.9M0.0%+1,364,495
Morgan Stanley6,223,322$398.4M0.0%−417,801
Norges Bank5,823,524$372.8M0.0%New
Dimensional Fund Advisors LP5,401,410$345.8M0.1%+1,971
Boston Partners5,153,347$329.8M0.3%+55,647
Van Eck Associates Corp4,482,631$286.9M0.2%+177,028
Goldman Sachs Group Inc4,446,565$284.6M0.0%+1,180,427
Northern Trust Corp3,938,748$252.1M0.0%−113,317
Bank Of America Corp /de/3,249,771$208.0M0.0%−882,969
Fmr LLC3,155,095$202.0M0.0%+379,982
Charles Schwab Investment Management Inc3,129,530$200.3M0.0%−27,496
Trian Fund Management, L.P.3,085,344$197.5M4.7%+3,081,300
Legal & General Group Plc2,771,907$177.4M0.0%−121,169
Bank of New York Mellon Corp2,639,900$169.0M0.0%−180,012
Manufacturers Life Insurance Company, The2,633,893$168.6M0.1%−717,905

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

8 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Mar 27, 2026Alan ArmstrongRepublican, SenateBuy$1,001 - $15,000−20.1%Report
Mar 25, 2026Terri A. SewellDemocratic, HouseSale$1,001 - $15,000+20.1%Report
Mar 23, 2026Warren DavidsonRepublican, HouseSale$1,001 - $15,000+19.6%Report
May 15, 2025Robert P. Bresnahan, Jr.Republican, HouseBuy$1,001 - $15,000−34.2%Report
Apr 8, 2025Robert P. Bresnahan, Jr.Republican, HouseSale$1,001 - $15,000+35.7%Report
Mar 27, 2025Austin ScottRepublican, HouseSale$1,001 - $15,000+49.9%Report
Feb 25, 2025Robert P. Bresnahan, Jr.Republican, HouseBuy$1,001 - $15,000−52.4%Report
Jan 4, 2023Austin ScottRepublican, HouseExchange$1,001 - $15,000Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How GE HealthCare is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARGE HealthCare Technologies Inc.2
  • CIK0001932393
  • Employer ID (EIN)88-251511617
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company17
  • Incorporated inDelaware17
  • Fiscal year endsDecember 312
  • Industry code (SIC)3844 X-Ray Apparatus & Tubes & Related Irradiation Apparatus2
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance2
  • Business address500 West Monroe Street, Chicago, IL 606612
  • Phone833-735-11392
  • Shares outstanding454,891,786 as of Apr 22, 202616
  • Public float$34.0B as of Jun 30, 202517
  • AuditorDeloitte & Touche LLP, Chicago, Illinois PCAOB ID 34; it also attests to the company’s internal control over financial reporting17
  • On EDGAR sinceJul 29, 20222
  • Filings442 in all: 4 (223), 8-K (53), 3 (30), 144 (14), 424B3 (12), 10-Q (11), CORRESP (9), SCHEDULE 13G/A (9)2
    All 35 form types

    SC 13G/A (8), 424B2 (6), FWP (6), UPLOAD (6), 10-K (4), ARS (4), DEF 14A (4), DEFA14A (4), EFFECT (4), SC 13G (4), SD (4), 10-12B/A (3), S-3ASR (3), SCHEDULE 13G (3), 424B4 (2), 8-K/A (2), DRS (2), S-1 (2), S-8 (2), 10-12B (1), 4/A (1), CERT (1), DRS/A (1), DRSLTR (1), POS AM (1), S-1/A (1), S-4 (1)

  • Latest filingsAnnual report (10-K) Feb 4, 2026
    Quarterly report (10-Q) Jul 29, 2026
    Proxy statement (DEF 14A) Mar 19, 2026
    Latest 8-K (8-K) Sep 22, 2026

Securities registered for trading

ClassSymbolExchange
Common stock, par value $0.01 per shareGEHCThe Nasdaq Stock Market LLC

From the cover page of the 10-K filed Feb 4, 2026 (Section 12(b) of the Exchange Act).17

Risk factors and legal proceedings

The risks GE HealthCare names in Item 1A of its 10-K filed Feb 4, 2026: 32 risks under these headings, as written.17

  • Industry and Economic Risks
  • Business and Operational Risks
  • Regulatory and Legal Risks
  • General Risks
  • We operate in highly competitive markets, competition may increase in the future, and our industry may be disrupted, requiring us to lower prices or resulting in a loss of market share.
  • Global geopolitical and economic instability, as well as continuing uncertainties and challenging conditions in regional economies, could adversely affect our business.
  • Public health crises and epidemics and pandemics have had and, in the future, may have a material adverse impact on our business, as well as on the operations and financial performance of customers and suppliers in industries that we serve.
  • Efforts by public and private payers to control the growth of healthcare costs may lead to lower reimbursements or increased utilization controls related to the use of our products by healthcare providers, which may affect the price of and demand for our products, services, or solutions.
  • Our inability to successfully complete strategic transactions could adversely affect our business.
  • If we do not successfully manage our collaboration arrangements, licensing arrangements, joint ventures, or strategic alliances with third parties, we may not realize the expected benefits from such arrangements, which could adversely affect our business.
  • Our increasing focus on and investment in cloud, edge computing, AI, and software offerings present risks to our business. We may not be successful in driving the global deployment and customer adoption of digital offerings, including cloud-enabled, AI-enabled, and software solutions.
  • Our inability to manage our supply chain or obtain supplies of components or raw materials has restricted, and could continue to restrict, the manufacturing of products, cause delays in delivery, or significantly increase our costs, and our use of third parties in various markets and their actions or inactions could affect our business.
The other 24 risks
  • Any interruption in the operations of our facilities, or our suppliers’, customers’, or third-party providers’ facilities, may impair our ability to deliver products or provide services.
  • Increased cybersecurity requirements, vulnerabilities, threats, and more sophisticated and targeted cybercrimes pose a risk to our systems, networks, products, solutions, services, and data, as well as our reputation, which could adversely affect our business.
  • We may be unable to obtain, maintain, protect, or effectively enforce our IP rights.
  • If we are unable to attract or retain key talent and qualified employees or maintain relations with our employees, unions, and other employee representatives, it could adversely affect our business.
  • Increasing attention to sustainability matters, including EH&S matters, may impose additional costs on our business and expose us to new risks.
  • Our research and development efforts may not succeed in developing commercially successful products and technologies, which could adversely affect our business.
  • The FDA and equivalent global agencies tightly regulate and actively enforce the laws and regulations governing the development, authorization, and commercialization of medical devices and pharmaceutical products.
  • The failure to comply with the FCPA and similar anti-corruption and anti-bribery laws globally has resulted in, and could continue to result in, civil or criminal sanctions and adversely affect our business.
  • We are subject to anti-kickback and false claims laws (including as these laws relate to off-label promotion of products) and failure to comply with these laws could adversely affect our business, including via sanctions and conditions on business activity.
  • We are subject to antitrust and competition laws that can result in sanctions and conditions on the way we conduct our business.
  • We are subject to stringent privacy laws and information security regulations.
  • Changes in applicable tax laws and regulations, as well as adverse outcomes of ongoing and future tax audits, could adversely affect our business and our ability to use deferred tax assets.
  • If the Spin-Off is determined to be a taxable transaction, it could result in significant tax liability to GE and its stockholders and we could have an indemnification obligation to GE, which could adversely affect our business, financial condition, cash flows, and results of operations.
  • We are subject to laws and regulations governing government contracts and public procurement, as well as policies of our customers on capital spending and government reimbursement and funding in many jurisdictions, as to which the failure to comply with or changes to such laws, regulations, or policies could adversely affect our business.
  • We are exposed to risks associated with product liability claims that have been and may be brought against us or as a result of the actions or inactions of our customers or third parties that are outside of our control.
  • We may become involved in litigation, arbitration, and governmental proceedings, including those stemming from third-party conduct beyond our control.
  • Developments following regulatory authorization, including results in post-approval device or pharmaceutical Phase 4 trials or other studies, could adversely affect sales or decrease demand for our medical devices or pharmaceutical products.
  • Complying with our requirements under our debt instruments could adversely affect our business, results of operations, cash flows, and financial condition.
  • We have significant postretirement benefit liabilities, including pension, healthcare, and life insurance benefit obligations, and the actual costs and related cash flows of these obligations are uncertain and could exceed current estimates.
  • Changes in foreign currency exchange rates, equity prices, and interest rates, and unfavorable changes in economic conditions or uncertainties that affect the capital markets, could adversely affect our financial performance.
  • Future material impairments in the value of our long-lived assets, including goodwill, could adversely affect our business.
  • Certain of our directors and employees may have actual or potential conflicts of interest because of their financial interests in GE or because of their previous or continuing positions with GE.
  • Our certificate of incorporation provides that certain state and federal courts in the State of Delaware will be the sole and exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.
  • Certain provisions in our certificate of incorporation, bylaws, and Delaware law may discourage takeovers and limit the power of our stockholders.

Legal proceedings

Information on material pending legal proceedings is incorporated herein by reference to the information set forth in Note 14, “Commitments, Guarantees, Product Warranties, and Other Loss Contingencies” to the financial statements included elsewhere in this Annual Report on Form 10-K.

The opening of Item 3, Legal Proceedings.17

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    Yahoo FinanceGEHC quote
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
    SEC EDGAROther events
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72